ZIMMER BIOMET HOLDINGS ($ZBH) is expected to release its quarterly earnings data on Thursday, August 7th before market open, per Finnhub. Analysts are expecting revenue of $2,073,380,570 and earnings of $2.00 per share.
You can see Quiver Quantitative's $ZBH stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
ZIMMER BIOMET HOLDINGS Insider Trading Activity
ZIMMER BIOMET HOLDINGS insiders have traded $ZBH stock on the open market 3 times in the past 6 months. Of those trades, 0 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $ZBH stock by insiders over the last 6 months:
- SANG YI (Group President, Asia Pacific) has made 0 purchases and 2 sales selling 1,800 shares for an estimated $169,011.
- LORI WINKLER (SVP and CHRO) sold 1,443 shares for an estimated $150,649
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
ZIMMER BIOMET HOLDINGS Hedge Fund Activity
We have seen 362 institutional investors add shares of ZIMMER BIOMET HOLDINGS stock to their portfolio, and 531 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- AMERIPRISE FINANCIAL INC added 3,208,596 shares (+236.0%) to their portfolio in Q1 2025, for an estimated $363,148,895
- ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC removed 1,806,549 shares (-99.5%) from their portfolio in Q2 2025, for an estimated $164,775,334
- JPMORGAN CHASE & CO added 1,524,718 shares (+273.9%) to their portfolio in Q1 2025, for an estimated $172,567,583
- FMR LLC removed 1,231,933 shares (-85.7%) from their portfolio in Q1 2025, for an estimated $139,430,176
- BOSTON PARTNERS removed 941,199 shares (-57.7%) from their portfolio in Q1 2025, for an estimated $106,524,902
- ALYESKA INVESTMENT GROUP, L.P. added 894,980 shares (+inf%) to their portfolio in Q1 2025, for an estimated $101,293,836
- AMERICAN CENTURY COMPANIES INC removed 670,930 shares (-11.3%) from their portfolio in Q1 2025, for an estimated $75,935,857
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
ZIMMER BIOMET HOLDINGS Government Contracts
We have seen $14,017,838 of award payments to $ZBH over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- BASE PLUS TWO YEAR SERVICE AGREEMENT. ROSA KNEE PREMIUM AND LITE WARRANTY: $197,500
- PREVENTIVE MAINTENANCE AND REPAIR SERVICE FOR ROSA ONE BRAIN SYSTEM: $196,000
- 4566299711!PECTUS BLU: $144,055
- 4566620076!PECTUS BLU: $141,330
- 4566988495!PECTUS BLU: $119,242
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
ZIMMER BIOMET HOLDINGS Congressional Stock Trading
Members of Congress have traded $ZBH stock 3 times in the past 6 months. Of those trades, 1 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $ZBH stock by members of Congress over the last 6 months:
- REPRESENTATIVE ROBERT BRESNAHAN has traded it 2 times. They made 1 purchase worth up to $15,000 on 04/08 and 1 sale worth up to $15,000 on 05/15.
- REPRESENTATIVE JULIE JOHNSON sold up to $15,000 on 02/11.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
ZIMMER BIOMET HOLDINGS Analyst Ratings
Wall Street analysts have issued reports on $ZBH in the last several months. We have seen 6 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- JMP Securities issued a "Market Outperform" rating on 05/07/2025
- Raymond James issued a "Outperform" rating on 05/06/2025
- Stifel issued a "Buy" rating on 05/06/2025
- RBC Capital issued a "Outperform" rating on 05/06/2025
- JP Morgan issued a "Overweight" rating on 05/06/2025
- Baird issued a "Outperform" rating on 05/06/2025
- Barclays issued a "Underweight" rating on 02/10/2025
To track analyst ratings and price targets for ZIMMER BIOMET HOLDINGS, check out Quiver Quantitative's $ZBH forecast page.
ZIMMER BIOMET HOLDINGS Price Targets
Multiple analysts have issued price targets for $ZBH recently. We have seen 14 analysts offer price targets for $ZBH in the last 6 months, with a median target of $108.5.
Here are some recent targets:
- Vijay Kumar from Evercore ISI Group set a target price of $96.0 on 07/08/2025
- William Plovanic from Canaccord Genuity set a target price of $101.0 on 05/12/2025
- David Turkaly from JMP Securities set a target price of $125.0 on 05/07/2025
- David Roman from Goldman Sachs set a target price of $104.0 on 05/06/2025
- Jayson Bedford from Raymond James set a target price of $104.0 on 05/06/2025
- Rick Wise from Stifel set a target price of $115.0 on 05/06/2025
- Shagun Singh from RBC Capital set a target price of $112.0 on 05/06/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
